Unexplained symptomatic paroxysmal hypertension in pseudopheochromocytoma: A stress response disorder?

Annals of the New York Academy of Sciences

Volumn 1148, Issue , 2008, Pages 469-478

  Eisenhofer, Graeme ^a   Sharabi, Yehonatan ^b   Pacak, Karel ^c  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b TEL AVIV UNIVERSITY   (Israel)

^c EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

Adrenal medulla; Catecholamines; Pheochromocytoma; Sympathetic nervous system

Indexed keywords

ADRENALIN; ADRENERGIC RECEPTOR; CATECHOLAMINE;

ADRENALIN RELEASE; AUTONOMIC NERVOUS SYSTEM; CARDIOVASCULAR RESPONSE; CLINICAL FEATURE; CONFERENCE PAPER; DIAGNOSTIC ERROR; DISEASE SEVERITY; DISTRESS SYNDROME; HUMAN; HYPERTENSION; PANIC; PHEOCHROMOCYTOMA; PSEUDOPHEOCHROMOCYTOMA; STRESS; SYMPTOMATIC PAROXYSMAL HYPERTENSION; SYMPTOMATOLOGY;

EID: 57749107570     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1410.019     Document Type: Conference Paper

References (46)

1. Manger, W.M. & R.W. Gifford. 1996. Clinical and Experimental Pheochromocytoma. Blackwell Science. Cambridge, MA.
2. Vaclavik, J. et al. 2007. Free plasma metanephrines as a screening test for pheochromocytoma in low-risk patients. J. Hypertens. 25 : 1427 1431.
3. DeQuattro, V., A.H. Margolin & L.O. Stocks. 1970. Pseudopheochromocytoma-adrenomedullary response to venography. J. Clin. Endocrinol. Metab. 30 : 138 140.
4. Lurvey, A., A. Yussin & V. DeQuattro. 1973. Pseudopheochromocytoma after self-administered isoproterenol. J. Clin. Endocrinol. Metab. 36 : 766 769.
5. Hyams, J.S. et al. 1985. Pseudopheochromocytoma and cardiac arrest associated with phenylpropanolamine. Jama. 253 : 1609 1610.
6. Mochizuki, T. et al. 1994. A pseudopheochromocytoma? Accumulation of I-123 MIBG in the renal pelvis. Clin. Nucl. Med. 19 : 1030 1031.
7. Messer-Kremer, M. et al. 1995. [Pseudopheochromocytoma in a parkinsonian patient treated with selegiline]. Rev. Med. Interne. 16 : 229 230.
8. Duarte, J. et al. 1996. Pseudopheochromocytoma in a patient with Parkinson's disease. Ann. Pharmacother. 30 : 546.
9. Hocqueloux, L., E. Mortier & J. Cabane. 1998. Pseudopheochromocytoma: an unrecognized cancer-associated syndrome? Arch. Intern. Med. 158 : 1381 1382.
10. Shah, B.R. et al. 2003. Pseudopheochromocytoma of pregnancy. Endocr. Pract. 9 : 376 379.
11. Jahnel, M. 2003. Pseudopheochromocytoma in Parkinson disease and depression. Psychiatr. Prax. 30 (Suppl 2 S64 S65.
12. Hoy, L.J. et al. 2004. Obstructive sleep apnea presenting as pseudopheochromocytoma: a case report. J. Clin. Endocrinol. Metab. 89 : 2033 2038.
13. Okosieme, O.E. & R.E. Morse. 2004. Pseudophaeochromocytoma in two young Africans. J R Soc. Med. 97 : 583 584.
14. Zornitzki, T., H. Knobler & A. Schattner. 2007. Reboxetine treatment and pseudopheochromocytoma. Qjm. 100 : 61 62.
15. Mann, S.J. 1996. Severe paroxysmal hypertension. An automatic syndrome and its relationship to repressed emotions. Psychosomatics 37 : 444 450.
16. Mann, S.J. 1999. Severe paroxysmal hypertension (pseudopheochromocytoma): understanding the cause and treatment. Arch. Intern. Med. 159 : 670 674.
17. Narkiewicz, K. & V.K. Somers. 1997. The sympathetic nervous system and obstructive sleep apnea: implications for hypertension. J. Hypertens. 15 : 1613 1619.
18. Netzer, N.C. et al. 1999. Using the Berlin Questionnaire to identify patients at risk for the sleep apnea syndrome. Ann. Intern. Med. 131 : 485 491.
19. Ketch, T. et al. 2002. Four faces of baroreflex failure: hypertensive crisis, volatile hypertension, orthostatic tachycardia, and malignant vagotonia. Circulation 105 : 2518 2523.
20. Sharabi, Y. et al. 2007. Sympathoadrenal function in patients with paroxysmal hypertension: pseudopheochromocytoma. J. Hypertension. 25 : 2286 2295.
21. Hamada, M. et al. 1995. Blood pressure response to the Valsalva maneuver in pheochromocytoma and pseudopheochromocytoma. Hypertension 25 : 266 271.
22. Tiensuu Janson, E.M. & K.E. Oberg. 1996. Carcinoid tumours. Baillieres Clin. Gastroenterol. 10 : 589 601.
23. Suchard, J.R. 1997. Recurrent near-syncope with flushing. Acad. Emerg. Med. 4 : 718 724.
24. Shibao, C. et al. 2005. Hyperadrenergic postural tachycardia syndrome in mast cell activation disorders. Hypertension 45 : 385 390.
25. Young, W.F., Jr. & D.E. Maddox. 1995. Spells: in search of a cause. Mayo Clin. Proc. 70 : 757 765.
26. Metz, S.A. et al. 1978. Autonomic epilepsy: clonidine blockade of paroxysmal catecholamine release and flushing. Ann. Intern. Med. 88 : 189 193.
27. Pinheiro, S. et al. 2004. [A case of epilepsy simulating a pheochromocytoma]. Rev. Neurol. 38 : 140 142.
28. Pacak, K. et al. 2007. Pheochromocytoma: recommendations for clinical practice from the First International Symposium. Nat. Clin. Pract. Endocrinol. Metab. 3 : 92 102.
29. White, W.B. & L.H. Baker. 1986. Episodic hypertension secondary to panic disorder. Arch. Intern. Med. 146 : 1129 1130.
30. Davies, S.J. et al. 1997. Panic disorder, anxiety and depression in resistant hypertension-a case-control study. J. Hypertens. 15 : 1077 1082.
31. Page, I.H. 1935. A syndrome simulating diencephalic stimulation occurring in patients with essential hypertension. Am J Med Sci. 190 : 9 14.
32. Kuchel, O. et al. 1982. Dopamine surges in hyperadrenergic essential hypertension. Hypertension 4 : 845 852.
33. Kuchel, O. 1985. Pseudopheochromocytoma. Hypertension 7 : 151 158.
34. Kuchel, O. et al. 1986. Episodic dopamine discharge in paroxysmal hypertension. Page's syndrome revisited. Arch. Intern. Med. 146 : 1315 1320.
35. Kuchel, O. 1998. Increased plasma dopamine in patients presenting with the pseudopheochromocytoma quandary: retrospective analysis of 10 years' experience. J. Hypertens. 16 : 1531 1537.
36. Chapman, J.N., et al. 2000. Page's syndrome: a case of pseudophaeochromocytoma. J. Hum. Hypertens. 14 : 149 150.
37. Eisenhofer, G. et al. 2005. Biochemical and clinical manifestations of dopamine-producing paragangliomas: utility of plasma methoxytyramine. J. Clin. Endocrinol. Metab. 90 (4 2068 2075.
38. Streeten, D.H. et al. 1990. Primary hyperepinephrinemia in patients without pheochromocytoma. Arch. Intern. Med. 150 : 1528 1533.
39. Rudy, F.R. et al. 1980. Adrenal medullary hyperplasia: a clinicopathologic study of four cases. Hum. Pathol. 11 : 650 657.
40. Dupont, A.G., P. Vanderniepen & E. Gerlo. 1985. A case of unilateral adrenal epinephrine excess: adrenal medullary hyperplasia? Acta Clin. Belg. 40 : 230 235.
41. Blum, I. et al. 1987. Adrenergic receptor hyperactivity - a cause for pseudopheochromocytoma? Med. Hypotheses 22 : 89 96.
42. Bailey, J. et al. 1999. Unilateral adrenal medullary hyperplasia: another form of curable hypertension? Int. J. Clin. Pract. 53 : 149 151.
43. Streeten, D.H. & G.H. Anderson, Jr. 1996. Mechanisms of orthostatic hypotension and tachycardia in patients with pheochromocytoma. Am. J. Hypertens. 9 : 760 769.
44. Luther, H.P., V. Homuth & G. Wallukat. 1997. Alpha 1-adrenergic receptor antibodies in patients with primary hypertension. Hypertension 29 : 678 682.
45. Illig, K.A. et al. 2006. An implantable carotid sinus stimulator for drug-resistant hypertension: surgical technique and short-term outcome from the multicenter phase II Rheos feasibility trial. J. Vasc. Surg. 44 : 1213 1218.
46. Tordoir, J.H. et al. 2007. An implantable carotid sinus baroreflex activating system: surgical technique and short-term outcome from a multi-center feasibility trial for the treatment of resistant hypertension. Eur. J. Vasc. Endovasc. Surg. 33 : 414 421.